ReviewTranslational lung cancer research2021

Disease control and objective responsive rates in randomized phase II trials evaluating non-first-line chemotherapy for non-small cell lung cancer: a systematic review of 74 trials.

Hiromi Matsumoto et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.